Observational study / 2014
Higher dietary lycopene intake was linked to a lower risk of lethal prostate cancer and less angiogenic potential in tumors.
In a prospective study of 49,898 male health professionals followed from 1986 through January 31, 2010, researchers evaluated dietary lycopene intake via questionnaires and tracked total and lethal prostate cancer cases. Higher lycopene intake was inversely associated with total prostate cancer and more strongly with lethal prostate cancer (top vs bottom quintile: HR = 0.72; 95% CI = 0.56 to 0.94; P trend = .04). In screened participants, the association for lethal prostate cancer was stronger (HR = 0.47; 95% CI = 0.29 to 0.75; P trend = .009). Early intake, but not recent intake, was inversely associated with prostate cancer, and higher intake was linked to tumor biomarkers indicating less angiogenic potential.
Shows an association, not proof of cause and effect.
- Study type
- Prospective cohort study
- Who was studied
- 49,898 male health professionals followed from 1986 to 2010
- What was measured
- Total and lethal prostate cancer, and tumor biomarkers of angiogenesis
THE PAPER
Dietary lycopene, angiogenesis, and prostate cancer: a prospective study in the prostate-specific antigen era.
Zu K, Mucci L, Rosner BA, Clinton SK, Loda M, Stampfer MJ, Giovannucci E. J Natl Cancer Inst, 2014.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.